INI1-negative Tumors
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma (NCT02601937) | Epizyme, Inc. | 2016-01-07 |
| A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma (NCT02601950) | Epizyme, Inc. | 2015-12-22 |
Track INI1-negative Tumors automatically
Every clearance here is in the API, with alerts when new ones post.